Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引：33

作者：

Sammond, DM ^{[1
]}

Nallor, KE ^{[1
]}

Veal, JM ^{[1
]}

Nolte, RT ^{[1
]}

Wang, LP ^{[1
]}

Knick, VB ^{[1
]}

Rudolph, SK ^{[1
]}

Truesdale, AT ^{[1
]}

Nartey, EN ^{[1
]}

Stafford, JA ^{[1
]}

Kumar, R ^{[1
]}

Cheung, M ^{[1
]}

机构：

[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 15期

关键词：

VEGFR2; FLK-1; KDR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2005.05.096

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3519 / 3523

页数：5

共 50 条

[1] Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis
Chen, Qingling
Chen, Zhuoying
Li, Feilong
Zha, Haoyu
He, Wei
Jiang, Fei
Wei, Jiamu
Xu, Jiajia
Li, Rong
Cai, Li
Liu, Xuesong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
[2] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
Lv, Yongcong
Li, Mengyuan
Liu, Ting
Tong, Linjiang
Peng, Ting
Wei, Lixin
Ding, Jian
Xie, Hua
Duan, Wenhu
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
[3] Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases
Claridge, Stephen
Raeppel, Franck
Granger, Marie-Claude
Bernstein, Naomy
Saavedra, Oscar
Zhan, Lijie
Llewellyn, David
Wahhab, Amal
Deziel, Robert
Rahil, Jubrail
Beaulieu, Normand
Nguyen, Hannah
Dupont, Isabelle
Barsalou, Annie
Beaulieu, Carole
Chute, Ian
Gravel, Serge
Robert, Marie-France
Lefebvre, Sylvain
Dubay, Marja
Pascal, Roussen
Gillespie, Jeff
Jin, Zhiyun
Wang, James
Besterman, Jeffrey M.
MacLeod, A. Robert
Vaisburg, Arkadii
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2793 - 2798
[4] Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel antiangiogenesis agent
Zongru Jiang
Li Wang
Xuesong Liu
Cheng Chen
Beilei Wang
Wenliang Wang
Chen Hu
Kailin Yu
Ziping Qi
Qingwang Liu
Aoli Wang
Jing Liu
Guangchen Hong
Wenchao Wang
Qingsong Liu
Acta Pharmaceutica Sinica B, 2020, 10 (03) : 488 - 497
[5] Discovery of New 4-Alkoxyquinazoline-Based Derivatives as Potent VEGFR2 Inhibitors
Yin, Yong
Sha, Shao
Wang, Yan-Ting
Wu, Xun
Wang, She-Feng
Qiao, Fang
Lv, Peng-Cheng
Zhu, Hai-Liang
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (05) : 1323 - 1329
[6] Discovery of thiazolidin-4-one urea analogues as novel multikinase inhibitors that potently inhibit FLT3 and VEGFR2
Qi, Baohui
Xu, Xingwei
Yang, Ying
Zhou, Yuting
Chen, Tao
Gong, Guowei
Yue, Xupeng
Xu, Xin
Hu, Liping
He, Huan
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (10) : 2127 - 2139
[7] Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
Jiang, Zongru
Wang, Li
Liu, Xuesong
Chen, Cheng
Wang, Beilei
Wang, Wenliang
Hu, Chen
Yu, Kailin
Qi, Ziping
Liu, Qingwang
Wang, Aoli
Liu, Jing
Hong, Guangchen
Wang, Wenchao
Liu, Qingsong
ACTA PHARMACEUTICA SINICA B, 2020, 10 (03) : 488 - 497
[8] Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors
Hou, Fei
Yao, Yuhong
Wei, Yujiao
Wang, Yubo
Cao, Yangzi
Liu, Xinqiang
Zheng, Liting
Zhang, Qingqing
Jiao, Yue
Chen, Yukun
Meng, Yue
Sun, Yue
Wu, Yanjie
Wang, Jiefu
Wang, Junfeng
Wu, Zhou
Zhang, Kun
Wei, Mingming
Yang, Guang
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 91
[9] Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor
Nguyen, Jennifer P.
Frost, Chelsea D.
Lane, Meghan L.
Skelton, William P.
Skelton, Michelle
Vesely, David L.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (10) : 1061 - 1067
[10] Discovery of dual inhibitors of pan-RAF and VEGFR2
Park, Eun Sun
Choi, Jihye
Hong, Sung Pyo
Kwon, Ho-Seok
Kim, Jinho
Ahn, Soon Kil
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2023, 44 (10) : 841 - 847

← 1 2 3 4 5 →